While research exists on C3 and C4 complement in neurodegeneration, much of it relates to Alzheimer’s disease (AD) or animal models, and so the present study wished to observe their concentrations within the parkinsonian disorders cohort of the study. The gene discussed is C3; the disease is Alzheimer disease.